MINI REVIEW article
Front. Cell Dev. Biol.
Sec. Molecular and Cellular Pathology
Phosphatases in Tumor Cell Immune Escape: A Perspective Based on the Camouflage, Coercion, Cytoprotection
Provisionally accepted- 1Nantong Tumor Hospital, Nantong, China
- 2Nantong University, Nantong, China
- 3Central South University, Changsha, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Tumor immune evasion represents a core challenge restricting the efficacy of cancer treatment, and a deep understanding of its underlying mechanisms is crucial for developing novel immunotherapeutic approaches. This article focuses on the multidimensional regulatory roles of protein phosphatases in this critical biological process, innovatively adopting the "three Cs" framework—camouflage, coercion, and cytoprotection—for systematic elaboration, thereby revealing phosphatases as core molecular switches within dynamic regulatory networks. Our review systematically demonstrates that protein phosphatases serve as indispensable "dynamic molecular switches" within the "three Cs" framework of tumor immune evasion. Their regulatory networks span the entire continuum of tumor cells evading recognition, inhibiting immune cell function, and resisting terminal immune attacks. This insight underscores the substantial potential of targeting phosphatase regulatory networks, which may overcome the drug resistance bottleneck encountered in current immunotherapies. By designing novel drug strategies to precisely intervene in key phosphatase nodes—thereby achieving "one target, multiple effects" synergistic regulation—this framework provides a robust theoretical foundation and promising new avenues for developing more efficient, broad-spectrum next-generation tumor immunotherapies.
Keywords: "three Cs" framework, Antigen Presentation, Immune checkpoint, metabolic reprogramming, Phosphatases, targeted therapy, tumor immune escape
Received: 12 Jun 2025; Accepted: 13 Jan 2026.
Copyright: © 2026 Zhang and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shudong Zhu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.